These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38473953)

  • 1. Molecular Targets of the 5-Amido-Carboxamide Bumped Kinase Inhibitor BKI-1748 in
    Ajiboye J; Uldry AC; Heller M; Naguleswaran A; Fan E; Van Voorhis WC; Hemphill A; Müller J
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473953
    [No Abstract]   [Full Text] [Related]  

  • 2. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
    Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice.
    Castellanos-Gonzalez A; Sparks H; Nava S; Huang W; Zhang Z; Rivas K; Hulverson MA; Barrett LK; Ojo KK; Fan E; Van Voorhis WC; White AC
    J Infect Dis; 2016 Dec; 214(12):1850-1855. PubMed ID: 27738055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Schaefer DA; Betzer DP; McCloskey MC; Whitman GR; Huang W; Lee S; Pranata A; McLeod MD; Marsh KC; Kempf DJ; LeRoy BE; Zafiratos MT; Bielinski AL; Hackman RC; Ojo KK; Arnold SLM; Barrett LK; Tzipori S; Riggs MW; Fan E; Van Voorhis WC
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0142522. PubMed ID: 36920244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolopyrimidine Bumped Kinase Inhibitors for the Treatment of Cryptosporidiosis.
    Hulverson MA; Choi R; Vidadala RSR; Whitman GR; Vidadala VN; Ojo KK; Barrett LK; Lynch JJ; Marsh K; Kempf DJ; Maly DJ; Van Voorhis WC
    ACS Infect Dis; 2021 May; 7(5):1200-1207. PubMed ID: 33565854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.
    Schaefer DA; Betzer DP; Smith KD; Millman ZG; Michalski HC; Menchaca SE; Zambriski JA; Ojo KK; Hulverson MA; Arnold SL; Rivas KL; Vidadala RS; Huang W; Barrett LK; Maly DJ; Fan E; Van Voorhis WC; Riggs MW
    J Infect Dis; 2016 Dec; 214(12):1856-1864. PubMed ID: 27923949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum.
    Huang W; Choi R; Hulverson MA; Zhang Z; McCloskey MC; Schaefer DA; Whitman GR; Barrett LK; Vidadala RSR; Riggs MW; Maly DJ; Van Voorhis WC; Ojo KK; Fan E
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533246
    [No Abstract]   [Full Text] [Related]  

  • 8. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Hulverson MA; Vinayak S; Choi R; Schaefer DA; Castellanos-Gonzalez A; Vidadala RSR; Brooks CF; Herbert GT; Betzer DP; Whitman GR; Sparks HN; Arnold SLM; Rivas KL; Barrett LK; White AC; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC; Ojo KK
    J Infect Dis; 2017 Apr; 215(8):1275-1284. PubMed ID: 28329187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy.
    Huang W; Hulverson MA; Choi R; Arnold SLM; Zhang Z; McCloskey MC; Whitman GR; Hackman RC; Rivas KL; Barrett LK; Ojo KK; Van Voorhis WC; Fan E
    J Med Chem; 2019 Mar; 62(6):3135-3146. PubMed ID: 30830766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry Imaging of In Vitro
    Anschütz NH; Gerbig S; Ghezellou P; Silva LMR; Vélez JD; Hermosilla CR; Taubert A; Spengler B
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627264
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.
    Lee S; Ginese M; Beamer G; Danz HR; Girouard DJ; Chapman-Bonofiglio SP; Lee M; Hulverson MA; Choi R; Whitman GR; Ojo KK; Arnold SLM; Van Voorhis WC; Tzipori S
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics reveals Cryptosporidium parvum infection disrupts cellular barriers.
    Wang L; Cui Z; Li N; Liang G; Zhang X; Wang Y; Li D; Li X; Zhang S; Zhang L
    J Proteomics; 2023 Sep; 287():104969. PubMed ID: 37463621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel CDPK1 inhibitor--a potential treatment for cryptosporidiosis in calves?
    Lendner M; Böttcher D; Delling C; Ojo KK; Van Voorhis WC; Daugschies A
    Parasitol Res; 2015 Jan; 114(1):335-6. PubMed ID: 25398685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of host protein ENO1 (alpha-enolase) interacting with Cryptosporidium parvum sporozoite surface protein, Cpgp40.
    Wang Y; Li N; Liang G; Wang L; Zhang X; Cui Z; Li X; Zhang S; Zhang L
    Parasit Vectors; 2024 Mar; 17(1):146. PubMed ID: 38504274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium parvum maintains intracellular survival by activating the host cellular EGFR-PI3K/Akt signaling pathway.
    Yang H; Zhang M; Wang X; Gong P; Zhang N; Zhang X; Li X; Li J
    Mol Immunol; 2023 Feb; 154():69-79. PubMed ID: 36621060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum.
    Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH
    PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative proteomics reveals Cryptosporidium parvum manipulation of the host cell molecular expression and immune response.
    Li T; Liu H; Jiang N; Wang Y; Wang Y; Zhang J; Shen Y; Cao J
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009949. PubMed ID: 34818332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro growth inhibition of Theileria equi by bumped kinase inhibitors.
    Gimenez F; Hines SA; Evanoff R; Ojo KK; Van Voorhis WC; Maly DJ; Vidadala RSR; Mealey RH
    Vet Parasitol; 2018 Feb; 251():90-94. PubMed ID: 29426483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis.
    Castellanos-Gonzalez A; White AC; Ojo KK; Vidadala RS; Zhang Z; Reid MC; Fox AM; Keyloun KR; Rivas K; Irani A; Dann SM; Fan E; Maly DJ; Van Voorhis WC
    J Infect Dis; 2013 Oct; 208(8):1342-8. PubMed ID: 23878324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.